series-b
Stage
1
Investors
About
2C Tech Corporation, Inc. develops nanoparticle-based medical technologies for ophthalmic applications, focusing on treatments and devices for retinal disorders. The company holds patents and has pursued clinical trials and grant-funded research related to its nanotech therapeutic pipeline.
Explore 2C Tech Corporation, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.